- All sections
- A - Human necessities
- A61K - Preparations for medical, dental or toiletry purposes
- A61K 31/42 - Oxazoles
Patent holdings for IPC class A61K 31/42
Total number of patents in this class: 1994
10-year publication summary
|
134
|
128
|
93
|
114
|
114
|
113
|
79
|
96
|
93
|
17
|
| 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
Principal owners for this class
| Owner |
All patents
|
This class
|
|---|---|---|
| Intervet Inc. | 909 |
45 |
| Theravance Biopharma R&D IP, LLC | 438 |
45 |
| Bristol-myers Squibb Company | 4792 |
28 |
| Intervet International B.V. | 1312 |
27 |
| Novartis AG | 10462 |
25 |
| Merck Sharp & Dohme Corp. | 2186 |
23 |
| Boehringer Ingelheim International GmbH | 4580 |
22 |
| The Regents of the University of California | 20427 |
20 |
| Amira Pharmaceuticals, Inc. | 66 |
19 |
| Glytech, LLC | 17 |
17 |
| Boehringer Ingelheim Animal Health USA Inc. | 420 |
17 |
| Gilead Sciences, Inc. | 2145 |
16 |
| Inserm (institut National de La Sante et de La Recherche Medicale) | 3353 |
15 |
| Pharnext | 84 |
15 |
| The Scripps Research Institute | 1341 |
15 |
| Merck Sharp & Dohme LLC | 3717 |
15 |
| Amgen Inc. | 4307 |
14 |
| Enanta Pharmaceuticals, Inc. | 433 |
14 |
| Proteostasis Therapeutics, Inc. | 68 |
14 |
| The United States of America, as represented by the Secretary, Department of Health and Human Services | 2952 |
14 |
| Other owners | 1574 |